TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Lundholms Sjukvård och medicinsk utveckling AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,838
|
2,070
|
1,010 |
| Financial expenses |
13
|
0
|
5 |
| Earnings before taxes |
-11
|
0
|
-19 |
| EBITDA |
-14
|
0
|
-13 |
| Total assets |
1,491
|
1,535
|
1,427 |
| Current assets |
978
|
1,023
|
930 |
| Current liabilities |
701
|
713
|
644 |
| Equity capital |
507
|
525
|
484 |
| - share capital |
44
|
45
|
45 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
34.0%
|
34.2%
|
33.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.6%
|
0%
|
-1.9% |
| Return on assets (ROA) |
0.1%
|
0%
|
-1.0% |
| Current ratio |
139.5%
|
143.5%
|
144.4% |
| Return on equity (ROE) |
-2.2%
|
0%
|
-3.9% |
| Change turnover |
-162
|
1,058
|
-1,472 |
| Change turnover % |
-8%
|
104%
|
-59% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.